Stock Fundamentals

Company Information

Company Name
Entrada Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US29384C1080
CIK: 0001689375
CUSIP: 29384C108
Currency: USD
Full Time Employees: 152
Phone: 857 520 9158
Fiscal Year End: December
IPO Date: Oct 29, 2021
Description:

Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle, therapeutic candidates are based on a novel therapeutic; a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases. Its preclinical product includes ENTR-601-44; ENTR-601-45; and VX-670. The company was formerly known as CycloPorters, Inc., and changed its name to Entrada Therapeutics, Inc., in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.

Address:

One Design Center Place, Boston, MA, United States, 02210

Directors & Officers

Name Title Year Born
Mr. Dipal Doshi CEO & Director 1976
Mr. Nathan J. Dowden President & COO 1971
Dr. Natarajan Sethuraman Ph.D. President of Research & Development 1962
Mr. Kory James Wentworth CPA CFO & Treasurer 1979
Dr. Jared Cohen J.D., Ph.D. General Counsel NA
Ms. Kerry Robert M.S. Senior Vice President of People NA
Ms. Karla MacDonald Chief Corporate Affairs Officer NA
Mr. Kevin Healy Ph.D. Senior Vice President of Regulatory Affairs NA
Sandeep Basnet Head of Information Technology NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 01, 2026 Kory James Wentworth N/A Sale 2.50K $12.95 $32.38K
Mar 10, 2026 Kory James Wentworth N/A Sale 11.39K $13.02 $148.27K
Mar 10, 2026 Nathan J Dowden N/A Sale 11.89K $13.05 $155.22K
Mar 09, 2026 Kory James Wentworth N/A Sale 5.09K $13.00 $66.16K
Mar 09, 2026 Nathan J Dowden N/A Sale 3.12K $13.02 $40.57K
Mar 04, 2026 Kory James Wentworth N/A Sale 7.99K $12.25 $97.85K
Nov 21, 2025 Kory James Wentworth N/A Sale 8.91K $9.98 $88.92K
Nov 14, 2025 Kush Parmar N/A Sale 200.00K $8.80 $1.76M
Nov 14, 2025 Ventures V L.P. 5Am N/A Sale 200.00K $8.80 $1.76M
Nov 12, 2025 Bros. Advisors Lp Baker N/A Purchase 100.74K $7.76 $781.71K
Nov 11, 2025 Bros. Advisors Lp Baker N/A Purchase 46.43K $7.50 $348.26K
Nov 10, 2025 Bros. Advisors Lp Baker N/A Purchase 30.87K $7.21 $222.60K
Jul 09, 2025 Kush Parmar N/A Sale 27.00K $7.50 $202.50K
Jul 09, 2025 Ventures V L.P. 5Am N/A Sale 20.07K $7.50 $150.49K
Jul 09, 2025 Ventures V L.P. 5Am N/A Sale 6.94K $7.50 $52.01K
Jun 30, 2025 Kush Parmar N/A Sale 25.00K $6.81 $170.25K
Jun 30, 2025 Ventures V L.P. 5Am N/A Sale 18.58K $6.81 $126.52K
Jun 30, 2025 Ventures V L.P. 5Am N/A Sale 6.42K $6.81 $43.73K
Jun 27, 2025 Kush Parmar N/A Sale 75.00K $6.91 $518.25K
Jun 27, 2025 Ventures V L.P. 5Am N/A Sale 55.74K $6.91 $385.13K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Baker Bros Advisors LP 5.07M Mar 31, 2026 13.07% $0.37 0.00%
5AM Venture Management, LLC 4.06M Mar 31, 2026 10.45% $14.21 0.00%
BlackRock Inc 2.36M Mar 31, 2026 6.08% $0.00 9.85%
TCG Crossover Management, LLC 2.29M Mar 31, 2026 5.89% $0.83 9.53%
Vanguard Group Inc 1.63M Dec 31, 2025 4.21% $0.00 1.76%
Vanguard Capital Management, LLC 1.26M Mar 31, 2026 3.24% $0.00 0.00%
Wellington Management Company LLP 1.03M Mar 31, 2026 2.67% $0.00 -0.95%
StepStone Group LLC 761.28K Mar 31, 2026 1.96% $4.63 0.00%
Geode Capital Management, LLC 667.35K Mar 31, 2026 1.72% $0.00 4.28%
State Street Corp 533.80K Mar 31, 2026 1.38% $0.00 4.92%
T. Rowe Price Associates, Inc. 526.04K Mar 31, 2026 1.36% $0.00 60.66%
Millennium Management LLC 519.36K Mar 31, 2026 1.34% $0.00 4.35%
Jones Hill Capital LP 374.01K Mar 31, 2026 0.96% $1.01 0.00%
Jacobs Levy Equity Management, Inc. 333.91K Mar 31, 2026 0.86% $0.02 -7.96%
Acadian Asset Management LLC 333.17K Mar 31, 2026 0.86% $0.01 2,779.34%
Dimensional Fund Advisors, Inc. 324.47K Mar 31, 2026 0.84% $0.00 18.69%
Northern Trust Corp 234.99K Mar 31, 2026 0.61% $0.00 3.84%
Vanguard Portfolio Management, LLC 220.49K Mar 31, 2026 0.57% $0.00 0.00%
Woodline Partners LP 215.98K Mar 31, 2026 0.56% $0.01 51.98%
Citadel Advisors Llc 215.02K Mar 31, 2026 0.55% $0.00 -26.56%

Shares Statistics

Shares Outstanding: 38.82M
Shares Float: 19.50M
% Insiders: 1,231.00%
% Institutions: 7,838.40%
Short % Float: 6.91%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 953.73K 2.46% ▲ 0.00% Apr 30, 2026
2 iShares Russell 2000 ETF 682.70K 1.76% ▲ 0.93% May 29, 2026
3 T. Rowe Price Health Sciences 295.98K 0.76% ▼ 10.10% Apr 30, 2026
4 Vanguard Institutional Extnd Mkt Idx Tr 283.54K 0.73% ▲ 3.69% Apr 30, 2026
5 Fidelity Small Cap Index 278.11K 0.72% ▲ 0.24% Mar 31, 2026
6 MEDICAL BioHealth EUR Acc 254.52K 0.66% ▲ 0.06% Apr 30, 2026
7 iShares Russell 2000 Value ETF 247.67K 0.64% ▲ 0.00% May 29, 2026
8 Russell 2000 Equity Index Fund B 193.45K 0.50% ▼ 0.04% Dec 31, 2025
9 iShares Biotechnology ETF 160.75K 0.41% ▲ 1.95% May 29, 2026
10 Vanguard Russell 2000 ETF 144.14K 0.37% ▲ 3.22% Apr 30, 2026

Valuation Metrics

Enterprise Value: $219.42M
Trailing P/E: 0.00
Forward P/E: 3.33K

Financial Highlights

Market Cap: $250.78M
EBITDA: $-172.56M
Book Value: $8.50
Earnings/Share: $-4.00
Profit Margin: 0.00%
Operating Margin: -4,834.63%
ROA (TTM): -26.84%
ROE (TTM): -48.28%
Revenue (TTM): $5.74M
Revenue/Share (TTM): $0.14
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -95.70%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 12.53x 0.01x 0.19x N/A -0.03x
2024-12-31 11.15x 0.02x 0.19x N/A 0.11x
2023-12-31 2.33x 0.03x 0.48x N/A 0.53x
2022-12-31 9.55x 0.04x 0.16x -36.95x -0.09x
2021-12-31 44.46x 0.00x 0.02x -1,649.26x 0.00x
2020-12-31 11.89x 0.00x 1.95x N/A 0.00x
2019-12-31 9.08x 0.00x 1.85x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about TRDA.US!